Home > Insider Trading > Filing (0001140361-13-010494)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1048477	Biomarin Pharmaceutical Inc	BMRN	Pharmaceutical Preparations (2834)	680397820

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1514980	Brian Mueller	105 Digital Drive Novato CA 94949	Vp, Corporate Controller	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2013-03-01	688	$38.59	15,982	No	4	M	Direct
Common Stock	Acquisiton	2013-03-01	730	$17.86	16,712	No	4	M	Direct
Common Stock	Acquisiton	2013-03-01	3,605	$14.39	20,317	No	4	M	Direct
Common Stock	Disposition	2013-03-01	5,023	$59.74	15,294	No	4	S	Direct
Common Stock	Acquisiton	2013-03-01	2,015	$59.81	13,279	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2013-03-01	688	$0.00	688	$38.59
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2013-03-01	730	$0.00	730	$17.86
Common Stock	Stock Option (right to buy) Common Stock	Disposition	2013-03-01	3,605	$0.00	3,605	$14.39

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
67,930	2008-11-22	2018-05-21	No	4	M	Direct
67,200	2009-06-17	2018-12-16	No	4	M	Direct
63,595	2009-11-12	2019-05-11	No	4	M	Direct

Footnotes

The price in column 4 is a weighted average price. The price actually received ranged from $59.73 to $59.745. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in column 4 is a weighted average price. The price actually received ranged from $59.79 to $59.821. The reportng person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
Original option grant vests 6/48th on November 22, 2008 and 1/48th each on the 22nd of each month thereafter.
Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.
Original option grant vests 6/48th on November 12, 2009 and 1/48th each on the 12th of each month thereafter.